FAP and neoplasm: For example, in a highly desmoplastic preclinical pancreatic ductal adenocarcinoma (PDAC) model, CAR-T cell targeting of FAP+ CAFs removes the physical and immunosuppressive CAF barrier, and enhances tumor infiltration of other T cell subsets.